Contact: to feature here

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
MedImmune LLC, Latest News & Vacancies
MedImmune LLC, is a US based biotechnology enterprise, acquired by AstraZeneca in 2007. It has its headquarters in Gaithersburg, Maryland. It was established by Wayne T. Hockmeyer as Molecular vaccines Inc. in 1988 and was changed to MedImmune in 1990. Company develops and manufactures immunological research based products, its most famous drugs are Synagis and FluMist.

In this forum we will discuss about its latest technologies, developments, recognitions and vacancies.
AstraZeneca small molecules and MedImmune's biologic research together are going to establish a center in Cambridge Biomedical Campus. An investment of 330 million pounds has been put up for a high-tech built-in facility for advanced research. The proposed destination will be all set to shine by 2016. Further company plans to put up its specialized R&D centers in UK, US and Sweden.
AstraZeneca's biological arm MedImmune acquired a newbie Alphacore pharma an Ann Arbor, Michigan based company focused on the development on ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme. Its a key component in the reverse cholesterol transport system, which plays a major role in removal of cholesterol from the body.
MedImmune won equipment innovation award for its UK Automation Upgrade Project in Speke, Liverpool, UK. MedImmune team used system design engineering for automation of full manufacturing train with each specialized discreet step. This extraordinary automation resulted into 15% increase in yield, 25% reduction in manual labor, 8% reduction in rejects or failures, and a decrease in waste at every stage of the process. This has a landmark in the automation industry.

Check out the MedImmune career website for extensive job offers in the field of biochemistry, molecular biology, bioprocess engineering and more.

[Image: medi.jpg]

Lets wait for another big news by MedImmune.
Kalpana Samant
Bioprocess Engineer & Freelancer
Like Post Reply
Flumist Quadrivalent Influenza Vaccine from MedImmune

MedImmune takes its pride to be the first in launching Flumist Quadrivalent, a vaccine for influenza and have successfully shipped the vaccine to US on 26th July 2013 making it available with all the influenza vaccine distributors and thus ensured their commitment to protect the health of the people from influenza infection during 2013-2014.

Salient Features of the Vaccine

Prick free. Yes it is the first vaccine available in the form of Nasal spray against influenza.

Contains two strains of Influenza A and two strains of Influenza B thus replaces the existing trivalent vaccine ( two strains of Influenza A and a single strain of Influenza B).

FDA approved.

Covered under the majority of the insurance plans supporting immunization.


The route of entry of the influenza virus is through the nose and this vaccination is administered as a nasal spray.

What to expect after Vaccination?

Runny nose
Stuffy nose
Sore throat

Eligible group for Vaccination

2 years old to 49 years old

Should not be allergic to egg and other compounds like gentamycin, gelatin and arginin.

Not Eligible for Vaccination

The group under 2 years – 17 years old who are on support of aspirin should not get vaccinated

People who had developed complications in their earlier influenza vaccination

Children under 5 years of age with wheezing

People with poor immune system

Pregnant women and breast feeding women

People with ailments related to kidneys, heart and lungs

People suffering from Guillain-Barre syndrome.

People who are on dosages of compounds like Tamiflu, Relenza , amantadine and rimantadine

Important rule

The vaccinated individual falling under the group of children and adolescent should stay away from aspirin for four long weeks and should consider taking advise from his or her health care provider after 4 weeks in case of necessity to take aspirin.

Literate yourself on the Flumist quadrivalent vaccine by visiting :
Like Post Reply

Possibly Related Threads…
Last Post
Replies: 3
Views: 24,030
02-18-2017, 05:29 PM
Last PostAbdul
Replies: 0
Views: 7,488
03-31-2016, 09:06 PM
Last PostHEL Group
Replies: 0
Views: 15,144
07-25-2015, 04:16 AM
Last Postgmshim
Replies: 1
Views: 17,791
03-26-2015, 04:12 PM
Last Postjuston33

Users browsing this thread:
1 Guest(s)

MedImmune LLC, Latest News & Vacancies00